PITPNM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PITPNM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PITPNM2 Human Pre-designed siRNA Set A contains three designed siRNAs for PITPNM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PITPNM3 Human Pre-designed siRNA Set A contains three designed siRNAs for PITPNM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PITRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PITRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PITX1 Human Pre-designed siRNA Set A contains three designed siRNAs for PITX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PITX2 Human Pre-designed siRNA Set A contains three designed siRNAs for PITX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PITX3 Human Pre-designed siRNA Set A contains three designed siRNAs for PITX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pivaloyloxymethyl chloride can be used as electrolyte solvent for lithium batteries, or used as alkylating agent to improve the biomembrane transport of an agent[1][2].

Pivmecillinam-d9 is deuterated labeled Pivmecillinam (HY-B0810). Pivmecillinam (FL-1039) is an orally active proagent of mecillinam, an extended-spectrum penicillin antibiotic.

PIWIL1 Human Pre-designed siRNA Set A contains three designed siRNAs for PIWIL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIWIL2 Human Pre-designed siRNA Set A contains three designed siRNAs for PIWIL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIWIL3 Human Pre-designed siRNA Set A contains three designed siRNAs for PIWIL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PIWIL4 Human Pre-designed siRNA Set A contains three designed siRNAs for PIWIL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pizotyline-d3 is deuterated labeled Pizotifen (HY-B0115). Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

PJA1 Human Pre-designed siRNA Set A contains three designed siRNAs for PJA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PJA2 Human Pre-designed siRNA Set A contains three designed siRNAs for PJA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PJVK Human Pre-designed siRNA Set A contains three designed siRNAs for PJVK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKC ζ pseudosubstrate, a PKC ζ inhibitor peptide, can be attached to cell permeabilization vector peptide[1].

PKC/PKD-IN-1 (Compound 13C) is an orally active dual protein kinase C/D (PKC/PKD) inhibitor with an IC50 value of 0.6 nM for PKD1. PKC/PKD-IN-1 can attenuate high-salt diet-induced cardiac hypertrophy and can be used in the study of heart failure[1].

PKCTheta-IN-1 (Compound 19) is a selective macrocyclic PKCTheta inhibitor with IC50 value of 0.1 nM[1].

PKD1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pkd1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pkd1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pkd1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pkd1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKD1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKD1L2 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKD1L3 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1L3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKD2 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pkd2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pkd2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pkd2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pkd2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKD2L1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD2L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKDCC Human Pre-designed siRNA Set A contains three designed siRNAs for PKDCC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKHD1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKHD1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKIA Human Pre-designed siRNA Set A contains three designed siRNAs for PKIA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKIB Human Pre-designed siRNA Set A contains three designed siRNAs for PKIB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKIG Human Pre-designed siRNA Set A contains three designed siRNAs for PKIG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKL-IN-1 (Compound 12a) is a potent pyruvate kinase L (PKL) inhibitor with IC50 values of 0.07 μM and 0.18 μM for PKL and PKR subtypes, respectively. PKL-IN-1 can inhibit 96.6% PKL activity at 10 μM concentration[1].

PKLR Human Pre-designed siRNA Set A contains three designed siRNAs for PKLR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKM Human Pre-designed siRNA Set A contains three designed siRNAs for PKM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pkm Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pkm gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pkm Rat Pre-designed siRNA Set A contains three designed siRNAs for Pkm gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PKM2-IN-6 (compound 7d) is a potent and orally active PKM2 inhibitor with an IC50 value of 23 nM. PKM2-IN-6 induces apoptosis and cell cycle arrest at G2 phase. PKM2-IN-6 reduces the level of PKM1 and PKM2 at the mRNA level. PKM2-IN-6 shows anticancer activity and has the potential for the research of triple-negative breast cancer[1].

PKMYT1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKMYT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.